Insider · CIK 0001867899

Tessari Eben

Reports to the SEC for 1 company · LONDON

sec.gov

Transactions

Companies

Filings

CIK

0001867899

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-04-07	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF STRATEGY OFFICER	MExercise/Conversion	+2,726 sh	—	—	23,976
2026-04-07	KNSAKiniksa Pharmaceuticals International, plcF Tax Payment	CHIEF STRATEGY OFFICER	FTax Payment	−846 sh	$48.94	−$41.4K	23,130
2026-04-07	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitM Exercise/Conversion	CHIEF STRATEGY OFFICER	MExercise/Conversion	−2,726 sh	—	—	0
2026-04-01	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF STRATEGY OFFICER	MExercise/Conversion	+5,975 sh	—	—	23,006
2026-04-01	KNSAKiniksa Pharmaceuticals International, plcF Tax Payment	CHIEF STRATEGY OFFICER	FTax Payment	−1,756 sh	$48.13	−$84.5K	21,250
2026-04-01	KNSAKiniksa Pharmaceuticals International, plc · Share OptionA Award	CHIEF STRATEGY OFFICER	AAward	+33.2K sh	—	—	33,200
2026-04-01	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitA Award	CHIEF STRATEGY OFFICER	AAward	+8,300 sh	—	—	8,300
2026-04-01	KNSAKiniksa Pharmaceuticals International, plc · Performance Share UnitA Award	CHIEF STRATEGY OFFICER	AAward	+16.6K sh	—	—	16,600
2026-04-01	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitM Exercise/Conversion	CHIEF STRATEGY OFFICER	MExercise/Conversion	−1,773 sh	—	—	1,772
2026-04-01	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitM Exercise/Conversion	CHIEF STRATEGY OFFICER	MExercise/Conversion	−1,745 sh	—	—	3,490
2026-04-01	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitM Exercise/Conversion	CHIEF STRATEGY OFFICER	MExercise/Conversion	−2,457 sh	—	—	7,371
2026-01-15	KNSAKiniksa Pharmaceuticals International, plcA Award	CHIEF STRATEGY OFFICER	AAward	+365 sh	$24.16	+$8,818.4	17,031
2025-12-15	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF STRATEGY OFFICER	MExercise/Conversion	+6,000 sh	$8.83	+$53K	28,714
2025-12-15	KNSAKiniksa Pharmaceuticals International, plcS Sale	CHIEF STRATEGY OFFICER	SSale	−12K sh	$41.56	−$501K	16,666
2025-12-15	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	CHIEF STRATEGY OFFICER	MExercise/Conversion	−6,000 sh	—	—	0
2025-11-26	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF STRATEGY OFFICER	MExercise/Conversion	+200 sh	$22.89	+$4,578	22,914
2025-11-26	KNSAKiniksa Pharmaceuticals International, plcS Sale	CHIEF STRATEGY OFFICER	SSale	−200 sh	$42.89	−$8,578	22,714
2025-11-26	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	CHIEF STRATEGY OFFICER	MExercise/Conversion	−200 sh	—	—	46,938
2025-11-17	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF STRATEGY OFFICER	MExercise/Conversion	+6,500 sh	$8.83	+$57.4K	35,184
2025-11-17	KNSAKiniksa Pharmaceuticals International, plcS Sale	CHIEF STRATEGY OFFICER	SSale	−645 sh	$40.08	−$25.9K	34,539
2025-11-17	KNSAKiniksa Pharmaceuticals International, plcS Sale	CHIEF STRATEGY OFFICER	SSale	−11.8K sh	$41.30	−$488K	22,714
2025-11-17	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	CHIEF STRATEGY OFFICER	MExercise/Conversion	−6,500 sh	—	—	6,000
2025-10-14	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF STRATEGY OFFICER	MExercise/Conversion	+6,500 sh	$8.83	+$57.4K	41,052
2025-10-14	KNSAKiniksa Pharmaceuticals International, plcS Sale	CHIEF STRATEGY OFFICER	SSale	−11.8K sh	$37.65	−$445K	29,237
2025-10-14	KNSAKiniksa Pharmaceuticals International, plcS Sale	CHIEF STRATEGY OFFICER	SSale	−553 sh	$37.99	−$21K	28,684
2025-10-14	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	CHIEF STRATEGY OFFICER	MExercise/Conversion	−6,500 sh	—	—	12,500
2025-09-29	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF STRATEGY OFFICER	MExercise/Conversion	+42K sh	$17.92	+$753K	76,552
2025-09-29	KNSAKiniksa Pharmaceuticals International, plcS Sale	CHIEF STRATEGY OFFICER	SSale	−42K sh	$38.33	−$1.61M	34,552
2025-09-29	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	CHIEF STRATEGY OFFICER	MExercise/Conversion	−42K sh	—	—	0
2025-09-15	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF STRATEGY OFFICER	MExercise/Conversion	+6,500 sh	$8.83	+$57.4K	50,952
2025-09-15	KNSAKiniksa Pharmaceuticals International, plcS Sale	CHIEF STRATEGY OFFICER	SSale	−16K sh	$36.45	−$585K	34,908
2025-09-15	KNSAKiniksa Pharmaceuticals International, plcS Sale	CHIEF STRATEGY OFFICER	SSale	−356 sh	$37.00	−$13.2K	34,552
2025-09-15	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	CHIEF STRATEGY OFFICER	MExercise/Conversion	−6,500 sh	—	—	19,000
2025-09-05	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF STRATEGY OFFICER	MExercise/Conversion	+13.4K sh	$15.52	+$208K	57,841
2025-09-05	KNSAKiniksa Pharmaceuticals International, plcS Sale	CHIEF STRATEGY OFFICER	SSale	−13.4K sh	$35.66	−$477K	44,452
2025-09-05	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	CHIEF STRATEGY OFFICER	MExercise/Conversion	−13.4K sh	—	—	0
2025-09-04	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF STRATEGY OFFICER	MExercise/Conversion	+38.7K sh	$15.50	+$600K	83,177
2025-09-04	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF STRATEGY OFFICER	MExercise/Conversion	+46.5K sh	$15.52	+$722K	129,723
2025-09-04	KNSAKiniksa Pharmaceuticals International, plcS Sale	CHIEF STRATEGY OFFICER	SSale	−85.3K sh	$35.52	−$3.03M	44,452
2025-09-04	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	CHIEF STRATEGY OFFICER	MExercise/Conversion	−38.7K sh	—	—	6,249
2025-09-04	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	CHIEF STRATEGY OFFICER	MExercise/Conversion	−46.5K sh	—	—	13,389
2025-09-03	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF STRATEGY OFFICER	MExercise/Conversion	+65 sh	$15.52	+$1,008.8	44,517
2025-09-03	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF STRATEGY OFFICER	MExercise/Conversion	+15K sh	$15.50	+$233K	59,543
2025-09-03	KNSAKiniksa Pharmaceuticals International, plcS Sale	CHIEF STRATEGY OFFICER	SSale	−15.1K sh	$35.50	−$536K	44,452
2025-09-03	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	CHIEF STRATEGY OFFICER	MExercise/Conversion	−65 sh	—	—	59,935
2025-09-03	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	CHIEF STRATEGY OFFICER	MExercise/Conversion	−15K sh	—	—	44,974
2025-09-02	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF STRATEGY OFFICER	MExercise/Conversion	+1,964 sh	—	—	45,402
2025-09-02	KNSAKiniksa Pharmaceuticals International, plcF Tax Payment	CHIEF STRATEGY OFFICER	FTax Payment	−950 sh	$34.28	−$32.6K	44,452
2025-09-02	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitM Exercise/Conversion	CHIEF STRATEGY OFFICER	MExercise/Conversion	−1,964 sh	—	—	0
2025-09-01	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	CHIEF STRATEGY OFFICER	MExercise/Conversion	+1,746 sh	—	—	41,961

Recent filings

Accepted (ET)
Apr 84
Tessari Eben0001867899-26-000004
SEC(opens sec.gov)
Apr 34
Tessari Eben0001867899-26-000002
SEC(opens sec.gov)
Dec 174
Tessari Eben0001867899-25-000013
SEC(opens sec.gov)
Dec 14
Tessari Eben0001867899-25-000011
SEC(opens sec.gov)
Nov 194
Tessari Eben0001867899-25-000009
SEC(opens sec.gov)

Companies

Kiniksa Pharmaceuticals International, plcCHIEF STRATEGY OFFICERKNSA

Address

C/O KINIKSA PHARMACEUTICALS INT'L 105 PICCADILLY, SECOND FLOOR

LONDON, W1J 7NJ